Zhejiang Wolwo Bio-Pharmaceutical Co. Ltd Financials

Market Capitalization CN¥15.75 Billion as of Jan. 1, 2026

Valuations Metrics as of Jan. 3, 2026

Trailing PE	37.80
Forward PE	30.82
Price to Sales TTM	CN¥14.16
Price to Book MRQ	CN¥5.63
Enterprise to Revenue	12.99
Enterprise to EBITDA	30.17

Financial Reports as of Jun. 30, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-06-30
Profit Margin	37.24%
Operating Margin	50.67%
Return on Assets TTM	8.91%
Return on Equity TTM	14.50%

Income Statement

Revenue TTM	CN¥1,048,516,608
Revenue per Share TTM	CN¥2.00
Quarterly Revenue Growth	22.60%
Gross Profit TTM	CN¥998,866,752
EBITDA	CN¥391,063,878
Net Income to Common TTM	CN¥390,434,912
Diluted EPS TTM	CN¥0.75
Quarterly Earnings Growth YoY	36.40%

Balance Sheet

Total Cash MRQ	CN¥1,341,947,264
Total Cash per Share MRQ	CN¥2.56
Total Debt MRQ	CN¥
Total Debt to Equity MRQ	0.71
Current Ratio MRQ	14.78
Book Value per Share MRQ	CN¥5.03

Cash Flow

Operating Cash Flow TTM	CN¥389,157,696
Levered Free Cash Flow TTM	CN¥115,787,328

300357 Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding	523,584,000
Float Shares	261,598,274
Avg 10 Volume	4,752,917
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	51.42%
% Held by Institutions	10.55%

Stock Price Summary

Beta	0.92
Fifty Two Week Low	CN¥18.23
Fifty Two Week High	CN¥35.84
Fifty Two Week Change	31.15%
Day 50 MA	CN¥31.08
Day 200 MA	CN¥26.12

Dividends and Splits

Forward Annual Dividend Rate	CN¥0.48
Forward Annual Dividend Yield	1.69%
Trailing Annual Dividend Rate	CN¥0.12
Trailing Annual Dividend Yield	0.42%
Payout Ratio	29.50%
Dividend Date
Ex Dividend Date	2025-07-08
Last Split Factor
Last Split Date	2019-05-08